Bg pattern

Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Insert: Information for the User

Hipromelosa STADA 3.2 mg/ml Eye Drops in Single-Dose Container

Read this package insert carefully before starting to use this medication, as it contains important information for you

  • Follow exactly the administration instructions contained in this package insert or those provided by your doctor or pharmacist.
  • Keep this package insert, as you may need to refer to it again.
  • For advice or further information, consult your pharmacist.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after3days.

1. What is Hipromelosa STADA and what is it used for

Hipromelosa STADA is a medication that belongs to the group of artificial tearsandis indicated for symptomatic relief of eye irritation and dryness.

You should consult a doctor if it worsens or does not improve after3days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Hipromelosa STADA

Do not use Hipromelosa STADA

If you are allergic to hypromellose or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Hipromelosa STADA.

If irritation, pain, redness, or changes in vision occur, or if you consider your condition to worsen, stop using this medicine and consult your doctor or pharmacist.

Use of Hipromelosa STADA with other medicines

Inform your doctor or pharmacist if you are using, have used recently, or might have to use any other medicine.

In intraocular application, no interactions with other medicines have been described to date.

Pregnancy and breastfeeding and fertility

If you are pregnant or breastfeeding, or if you think you might be pregnant, consult your doctor or pharmacist before using this medicine.

No experience is available regarding the safety of this product during pregnancy or breastfeeding.

Driving and operating machines

No effects on the ability to drive or operate machinery have been described due to the use of Hipromelosa STADA.

Hipromelosa STADA contains sodium dodecahydrate hydrogen phosphate and dihydrogen sodium phosphate dihydrate

This medicine contains 0.95 mg of phosphates in each single-dose container, equivalent to 1.9 mg/ml.

If you suffer from severe damage to the cornea (the transparent layer at the front of the eye), treatment with phosphates, in very rare cases, may cause blurred vision due to calcium accumulation.

3. How to use Hipromelosa STADA

Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

Hipromelosa STADA is used by ocular route, as eye drops.

The recommended dose is one drop in the affected eye(s) 3 to 5 times a day or, if necessary, more frequently or as indicated by your specialist.

Ensure the single-use container is intact before use. The solution must be used immediately after opening. To avoid possible contamination of the dropper and solution, the dropper should not come into contact with the eye or any other surface.

Wash your hands before use.

For correct administration, follow the following instructions:

  1. Remove a single-use container from the strip.
  1. Check that the single-use container is not damaged.
  2. Hold the single-use container between the index and thumb of one hand.

With the index and thumb of the other hand, perform a light lever action on the winged piece to open it. Do not turn to break.

  1. Gently pull to remove the winged piece.
  1. Gently pull downwards from the lower eyelid to form a pouch. Turn the single-use container downwards and squeeze it to apply one drop to each eye. Blink a couple of times.

Do not use the single-use container again even if there is solution remaining.

The treatment of dry eye syndrome requires an individualized dosing regimen.

If you are using more than one eye drop medication, the applications of the different medications should be spaced at least 5 minutes apart.

If you use more Hipromelosa STADA than you should

If you have used more Hipromelosa STADA than you should, consult your doctor or pharmacist immediately.

No ocular overdoses are known and no ocular overdose effects are anticipated with the ocular administration route.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service Telephone 91 562 04 20 indicating the medication and the amount administered or ingested.

If you forgot to use Hipromelosa STADA

Do not use a double dose to compensate for the missed doses.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not all people will experience them.

You may experience the following adverse effects:

Rare(may affect between 1 and 10 out of every 1,000 patients): burning sensation, blurred vision, and sticky eyelids.


Reporting Adverse Effects

If you experience any type of adverse effect,consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use. https:/www.notificaram.es.

By reporting adverse effects, you can contribute to providing more information about the safety of this medication.

5. Conservation of Hypromellose STADA

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.

Do not store at a temperature above 30°C.

Store single-dose containers in the original packaging.

Dispose of the opened single-dose container after use (do not reuse the container once opened for subsequent doses).

Do not use this medication if you observe that the solution changes color or becomes turbid.

Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the Pharmacy Take-Back Pointof your pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of Hipromelosa STADA

  • The active ingredient is hypromellose. Each milliliter of solution contains 3.20 mg of hypromellose.
  • The other components aremonohydrate sodium phosphate dodecahydrate, dihydrate sodium dihydrogen phosphate, sorbitol(E420)and water forinjectable preparations.

Appearance of the product and contents of the packaging

Hypromellose STADA eye drops in solution are presented in single-dose containers of 0.5 ml of sterile solution. Each cardboard box containsa foil pouch with30single-dose containers.

Marketing Authorization Holder

STADA Laboratory, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern (Barcelona)

Spain

[email protected]

Responsible for Manufacturing

Neuraxpharm Pharmaceuticals, S.L.

Avda. Barcelona, 69

08970 Sant Joan Despí (Barcelona)

Spain

Last review date of this leaflet:May 2022

The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es

Online doctors for Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis

Discuss questions about Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis?
Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis?
The active ingredient in Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis is artificial tears and other indifferent preparations. This information helps identify medicines with the same composition but different brand names.
Who manufactures Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis?
Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis is manufactured by Laboratorio Stada S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to Hipromelosa stada 3,2 mg/ml colirio en solucion en envase unidosis?
Other medicines with the same active substance (artificial tears and other indifferent preparations) include ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media